title: Platelet inhibition and cancer promotion.
authors.forename: Mark R
authors.initials: MR
authors.lastname: Goldstein
authors.forename: Luca
authors.initials: L
authors.lastname: Mascitelli
authors.forename: Francesca
authors.initials: F
authors.lastname: Pezzetta
mesh_terms: D000818:Animals; D004730:Endothelium, Vascular / Q000166:cytology / Q000187:drug effects; D006801:Humans; D009369:Neoplasms / Q000098:blood supply / Q000139:chemically induced*; D009389:Neovascularization, Pathologic / Q000139:chemically induced; D010879:Piperazines / Q000009:adverse effects*; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects*; D000068799:Prasugrel Hydrochloride; D013154:Spleen / Q000166:cytology / Q000187:drug effects; D013234:Stem Cells / Q000166:cytology / Q000187:drug effects; D050378:T-Lymphocytes, Regulatory / Q000473:pathology; D013876:Thiophenes / Q000009:adverse effects*
chemical_list: D010879:Piperazines; D010975:Platelet Aggregation Inhibitors; D013876:Thiophenes; D000068799:Prasugrel Hydrochloride